Consistent with the findings obtained from NSCLC cell lines, we observed a dose-dependent decrease in cell migration upon TRPM7 inhibition in multiple primary lung cancer cells (Fig. 2g and Supplementary Fig. S5). Here, TRPM7 is linked to lung cancer.